| Financial Year |
March 31 2023 |
| Monetary Funds |
280,612,643.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
94,000,218.48 |
| Accounts Receivable |
620,696,532.83 |
| Advances to Suppliers |
48,338,214.20 |
| Other Receivables |
22,595,502.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
371,230,320.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,584,219.22 |
| Total Current Assets |
1,450,589,206.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,587,922.56 |
| Investment Properties |
-- |
| Fixed Assetes |
101,463,919.28 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
427,468,417.03 |
| R&D expenses |
81,898,499.00 |
| Goodwill |
16,257,044.97 |
| Long-Term Deferred and Prepaid Expenses |
9,138,655.85 |
| Deferred Income Tax Assets |
55,052,656.45 |
| Other Non-Current Assets |
4,707,019.47 |
| Sub-Total of Non-Current Assets |
826,788,880.93 |
| Total Assets |
2,277,378,087.27 |
| Short-Term Loans |
43,823,811.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
29,262,218.18 |
| Accounts Payable |
225,571,176.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,341,472.67 |
| Taxes Payable |
73,057,671.75 |
| Interest Payable |
-- |
| Dividend Payable |
1,536,585.37 |
| Other payables |
7,482,689.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,500,416.12 |
| Other Current Liabilities |
1,252,158.87 |
| Sub-Total of Current Liabilities |
462,442,554.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,933,806.53 |
| Deferred Income Tax Liabilities |
24,713,076.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
84,645,587.83 |
| Total Liabilities |
547,088,142.70 |
| Paid-In Capital(Or Share Stock) |
662,675,236.00 |
| Capital Surplus |
1,052,138,066.41 |
| Surplus Reserve |
38,573,348.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-29,391,317.08 |
| Minority Stockholder's Interest |
7,998,720.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,722,291,224.02 |
| Owner's Equity（Stockholder's Equity） |
1,730,289,944.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,277,378,087.27 |
